Health Care & Life Sciences » Pharmaceuticals | Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc.

Aclaris Therapeutics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.97
Market Cap
$97.4 M
Shares Outstanding
41.27 M
Public Float
33.85 M

Profile

Address
640 Lee Road
Malvern Pennsylvania 19087
United States
Employees -
Website http://www.aclaristx.com
Updated 07/08/2019
Aclaris Therapeutics, Inc. is a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address unmet needs in medical and aesthetic dermatology and immunology. It operates thrpough Dermatology Therapeutics and Contract Research segments. The Dermatology Therapeutics segment focuses in identifying, developing, and commercializing innovative and differentiated therapies to address significant unmet needs in medical and aesthetic dermatology.

Financials

View All
Created with Highcharts 5.0.14Aclaris Therapeutics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.6 9766 97610 57110 57120 56320 56348 07948 07968 52368 523132 738132 738201320142015201620172018025k50k75k100k125k150k
Created with Highcharts 5.0.14Aclaris Therapeutics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.000000001 6831 68310 09110 09120132014201520162017201802.5k5k7.5k10k12.5k

Neal S. Walker
President, Chief Executive Officer & Director
Stephen A. Tullman
Chairman